Funded Tech Companies

Carbylan Therapeutics

Researching who invested in Carbylan Therapeutics? Private investors, Vivo Capital and InterWest Partners joined the equity holders in this innovative medical devices company.

Company Overview

Company Name
Carbylan Therapeutics
Company Status
Publicly-held
Funding Rounds

Contact Information

Mailing Address
3181 Porter Dr.
Palo Alto, CA 94304
USA
Email Address

Company Background Information

Overview
Carbylan was founded in 2005 to develop and market medical devices and device/drug combination products
Profile
Carbylan Therapeutics LinkedIn Company Profile
Social Media
Carbylan Therapeutics Company Twitter Account
Company News
Carbylan Therapeutics News
Facebook
Carbylan Therapeutics on Facebook
YouTube
Carbylan Therapeutics on YouTube
Last Transaction
4/9/2015

Financing History

Date
Type
Amount
IPO
$65,000,000
Debt
$4,000,000
Debt
$5,000,000
Venture Equity
$5,999,999
Venture Equity
$20,000,000
Venture Equity
$7,900,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
David Renzi
  David Renzi LinkedIn Profile  David Renzi Twitter Account  David Renzi News  David Renzi on Facebook
Chief Financial Officer
Michael White
  Michael White LinkedIn Profile  Michael White Twitter Account  Michael White News  Michael White on Facebook
VP - R & D
David Gravett
  David Gravett LinkedIn Profile  David Gravett Twitter Account  David Gravett News  David Gravett on Facebook
VP - Regulatory Affairs
Hayley Lewis
  Hayley Lewis LinkedIn Profile  Hayley Lewis Twitter Account  Hayley Lewis News  Hayley Lewis on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Carbonstop | Carbyne

 

Share this article

 


About Our Venture Capital Database

The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary